| Market Cap | ₹22,132Cr |
| ROE | 12.09% |
| P/E Ratio(TTM) | 92.16 |
| EPS(TTM) | 187.18 |
| P/B Ratio | 13.67 |
| Dividend Yield | 0.07% |
| Industry P/E | 33.51 |
| Book Value | 1262.09 |
| Debt to Equity | 0.16 |
| Face Value | 10 |
| Parent Organisation | Neuland Laboratories Limited |
| Managing Director | Mr. Davuluri Rao |
| NSE Symbol | NEULANDLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 69.17 | ||
| Jubilant Pharmova | NA (0.00%) | 38.17 | ||
| Acutaas Chemicals | NA (0.00%) | 62.10 | ||
| Gujarat Themis Biosyn | NA (0.00%) | 98.06 |